Navigation Links
Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
Date:8/27/2007

TEL AVIV, Israel, August 27 /PRNewswire-FirstCall/ -- Notice is hereby given that the 2007 Annual General Meeting (the "Annual Meeting") of the Shareholders of Rosetta Genomics Ltd. (NASDQ:ROSG) (the "Company"), an Israeli company, will be held at the offices of Yigal Arnon & Co., Azrieli Center, Round Tower, 47th floor, Tel Aviv, Israel on Monday, September 24, 2007, at 11:00 a.m. (Israel time) for the following purposes:

1. To approve the appointment of Kost, Forer, Gabbay & Kasierer (a member of Ernst & Young Global), as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2007 and its service as the Company's independent registered public accounting firm until the next Annual General Meeting and to authorize the Board of Directors of the Company, upon recommendation of the Audit Committee, to fix remuneration of said firm; and

2. To report on the business of the Company for the year ended December 31, 2006 (including a review of the 2006 audited consolidated financial statements).

The affirmative vote of the holders of a majority of the voting power represented at the meeting in person or by proxy, and voting thereon, is necessary for the approval of the first proposal.

Shareholders of record at the close of business on August 31, 2007, are entitled to notice of, and to vote at, the Annual Meeting. All shareholders are cordially invited to attend the Annual Meeting in person.

A proxy statement describing the matter to be voted upon at the meeting with a proxy card enabling the Shareholders to indicate their vote on such matter will be mailed on or around September 2, 2007 to all Shareholders entitled to vote at the Annual Meeting and is also available on the Company's website at http://www.rosettagenomics.com and on the SEC's website at http://www.sec.gov.

Shareholders who do not expect to attend the Meeting in person are requested to mark, date, sign and mail the proxy card to the office of the Company's transfer agent, American Stock Transfer & Trust Company located at 6201 15th Ave, Brooklyn, NY 11219, not less than twenty four (24) hours before the time fixed for the Annual Meeting in order to be qualified to participate in meeting.

About Rosetta Genomics

Rosetta Genomics (Nasdaq: ROSG) is a leader in the development of microRNA-based diagnostics and therapeutics. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and strategic alliances with leading biotechnology companies, Rosetta Genomics is working to develop a full range of diagnostic and therapeutic products based on microRNAs. The company's primary focus is in the development of microRNA-based products to diagnose and treat different forms of cancer and infectious diseases.

Contact:

Media

Alan Zachary

T: +1-(312)-944-6784

media@rosettagenomics.com

Investors

Juliane Snowden

T: +1-(212)-213-0006

investors@rosettagenomics.com


'/>"/>
SOURCE Rosetta Genomics Ltd
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. The DIG System Nonradioactive Automated High-Throughput In Situ Hybridization: a Powerful Tool for Functional Genomics Research
2. Genomics researcher Hood joins NimbleGen board
3. GE Healthcare partners with genomics institute
4. Speaker announces business members of IT Task Force
5. Doyle announces technology tax credits for Berbee
6. Doyle announces new energy, global warming policies
7. Doyle announces $80M renewable energy strategy
8. GE announces first installation of Discovery VCT
9. UWM announces winners of RGI awards
10. Third Wave announces two senior management appointments
11. Mirus announces new method for making antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... 2016  Allergan plc (NYSE: AGN ) a ... Saunders , Allergan,s CEO and President, will be featured ... at the RBC Capital Markets Healthcare Conference on Tuesday, ... New York Palace Hotel in New York, ... and can be accessed on Allergan,s Investor Relations web ...
(Date:2/10/2016)... MO (PRWEB) , ... February 10, 2016 , ... ... will attend the International Society of Pharmaceutical Engineering (ISPE) Rocky Mountain Chapter 21st ... ISPE is expecting to fill more than 100 tables for its annual event, ...
(Date:2/10/2016)... Mateo, CA (PRWEB) , ... February 10, 2016 ... ... of Multiplex Testing (PROMPT), a research registry built on the secure online PatientCrossroads ... September 2014. More than 1,600 participants have joined the PROMPT study, which seeks ...
(Date:2/10/2016)... La Jolla CA (PRWEB) , ... February 10, 2016 , ... ... of new agents for the treatment of Alzheimer’s disease, announced today it has been ... to February 18th at the Breakers in Palm Beach, Florida. The purpose of ...
Breaking Biology Technology:
(Date:2/9/2016)... Vigilant Solutions announces today that an agency used ... a lead in a difficult homicide case. The agency then ... the suspect vehicle. Due to the ongoing investigation, the agency ... at the agency,s request. --> ... was found deceased at an intersection here in the City. ...
(Date:2/3/2016)... February 4, 2016 --> --> ... 1,351.5 M (105.0), up 1,187% compared with fourth quarter of 2014. ... SEK 517.6 M (loss: 30.0). Earnings per share increased to ... SEK 537.4 M (neg: 74.7). , --> ... amounted to SEK 2,900.5 M (233.6), up 1,142% compared with 2014. ...
(Date:2/2/2016)... , Feb. 2, 2016  BioMEMS ... are primarily focused on medical screening and ... point-of-care parameters. Wearable devices that facilitate and ... freedom of movement are being bolstered through ... human biomedical signal acquisition coupled with wireless ...
Breaking Biology News(10 mins):